STOCK TITAN

Advanced Drainage Systems Announces Third Quarter Fiscal 2021 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Advanced Drainage Systems, Inc. (NYSE: WMS) reported strong financial results for Q3 of FY 2021, with net sales up 23.6% to $486.1 million and net income soaring 128.4% to $54.0 million. Year-to-date results highlighted an 18.1% sales increase to $1.5 billion and a significant turnaround in net income, reaching $205.3 million compared to a loss of $195.3 million last year. Adjusted EBITDA rose 52.1% to $138.9 million in Q3 and 63.0% to $472.4 million year-to-date. The company anticipates net sales for FY 2021 to reach between $1.915 billion and $1.950 billion.

Positive
  • Net sales increased 23.6% to $486.1 million in Q3 FY2021.
  • Net income surged 128.4% to $54.0 million in Q3 FY2021.
  • Adjusted EBITDA rose 52.1% to $138.9 million in Q3.
  • Year-to-date net income improved to $205.3 million from a $195.3 million loss.
  • Free cash flow increased 56.4% to $391.1 million year-to-date.
  • Increased FY2021 net sales guidance to $1.915 billion-$1.950 billion.
Negative
  • None.

Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading provider of innovative water management solutions in the stormwater and on-site septic waste water industries today announced financial results for the third quarter ended December 31, 2020.

Third Quarter Fiscal 2021 Results

  • Net sales increased 23.6% to $486.1 million
  • Net income increased 128.4% to $54.0 million
  • Adjusted EBITDA (Non-GAAP) increased 52.1% to $138.9 million

Year-to-Date Fiscal 2021 Results

  • Net sales increased 18.1% to $1.5 billion
  • Net income increased to $205.3 million, compared to a net loss of $195.3 million in the prior year
  • Adjusted EBITDA (Non-GAAP) increased 63.0% to $472.4 million
  • Cash provided by operating activities increased 51.5% to $448.8 million
  • Free cash flow (Non-GAAP) increased 56.4% to $391.1 million

Scott Barbour, President and Chief Executive Officer of ADS commented, “We delivered a record third quarter in fiscal 2021. Sales grew 24% year-over-year, driven by 17% non-residential sales growth and 36% residential sales growth as we continued to execute on our material conversion strategy in the favorable demand environment. We experienced strong demand in key growth states in the South and Southeast regions of the United States, as well as the return of demand in the Western and Northeast regions of the United States. In addition, sales in the agriculture market increased 33%, driven by the programs we put in place around organizational changes, new product introductions and improving execution in the strong fall selling season. Overall, we executed well this quarter to meet the growing demand for our products and solutions and continue to benefit from our national presence as well as our favorable geographic and end market exposure.”

Barbour continued, “We also achieved record profitability in the third quarter. Our Adjusted EBITDA margin expanded 540-basis points this quarter, our first full quarter of comparable results from the Infiltrator business. In addition to capturing the benefits of leverage from our strong sales growth, both companies successfully offset inflationary costs through favorable pricing, operational productivity initiatives and our synergy programs.”

Barbour concluded, “As we move toward the end of our fiscal year, we are optimistic about our business outlook as our order book, project tracking, book-to-bill ratio and backlog continue to be favorable on a year-over-year basis. We are well positioned to capitalize on growing residential development and horizontal construction, while continuing to generate above-market growth through the execution of our material conversion and water management solutions strategies. We remain focused on disciplined execution as we build on our strong year-to-date results.”

Third Quarter Fiscal 2021 Results

Net sales increased $92.7 million, or 23.6%, to $486.1 million, as compared to $393.4 million in the prior year. Domestic pipe sales increased $46.3 million, or 22.3%, to $254.2 million. Domestic allied products & other sales increased $20.7 million, or 23.3%, to $109.6 million. Infiltrator sales increased $26.3 million, or 36.5%, to $98.4 million. These increases were driven by double-digit sales growth in both the U.S. construction and agriculture end markets.

Gross profit increased $45.1 million, or 36.6%, to $168.5 million as compared to $123.4 million in the prior year. The increase is primarily due an increase in sales volume of pipe, on-site septic and allied products; favorable pricing and material cost; and operational improvements offsetting inflationary costs.

Adjusted EBITDA (Non-GAAP) increased $47.5 million, or 52.1%, to $138.9 million, as compared to $91.3 million in the prior year. The increase is primarily due to the factors mentioned above. As a percentage of net sales, Adjusted EBITDA was 28.6% as compared to 23.2% in the prior year.

Reconciliations of GAAP to Non-GAAP financial measures for Adjusted EBITDA and Free Cash Flow have been provided in the financial statement tables included in this press release. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures.”

Year-to-Date Fiscal 2021 Results

Net sales increased $235.9 million, or 18.1%, to $1.539 billion, as compared to $1.303 billion in the prior year. Domestic pipe sales increased $68.5 million, or 9.1%, to $820.0 million. Domestic allied products & other sales increased $29.1 million, or 9.2%, to $344.5 million. These increases were driven by growth in both the U.S. construction and agriculture end markets. Infiltrator sales increased $169.6 million, or 123.8%, to $306.5 million, as compared to $137.0 million in the prior year.

Gross profit increased $355.1 million to $562.9 million as compared to $207.7 million in the prior year. The prior year gross profit includes $168.6 million of ESOP special dividend compensation expense. In addition, the year-to-date gross profit includes an incremental benefit from a full year of results from the Infiltrator Water Technologies business, as compared to five months of results in the prior year due to the timing of the acquisition. The remaining increase in gross profit was due to favorable material cost, increases in both pipe and allied product sales and an increase in operational efficiency.

Adjusted EBITDA (Non-GAAP) increased $182.6 million, or 63.0%, to $472.4 million, as compared to $289.8 million in the prior year. The increase is primarily due to the factors mentioned above. As a percentage of net sales, Adjusted EBITDA was 30.7% as compared to 22.2% in the prior year.

Balance Sheet and Liquidity

Net cash provided by operating activities increased $152.5 million, or 51.5%, to $448.8 million, as compared to $296.3 million in the prior year. Free cash flow (Non-GAAP) increased $141.1 million, or 56.4%, to $391.1 million, as compared to $250.0 million in the prior year. Net debt (total debt and finance lease obligations net of cash) was $619.8 million as of December 31, 2020, a decrease of $368.1 million from March 31, 2020.

ADS had total liquidity of $563 million, comprised of cash of $224 million as of December 31, 2020 and $339 million of availability under committed credit facilities. As of December 31, 2020, the Company’s leverage ratio was 1.1 times.

Fiscal 2021 Outlook

ADS continues to carefully monitor the pandemic and the impact on its business. Based on current visibility, backlog of existing orders and business trends, the Company increased its net sales and Adjusted EBITDA targets for fiscal 2021. Net sales are expected to be in the range of $1.915 billion to $1.950 billion and Adjusted EBITDA is expected to be in the range of $550 to $565 million. Capital expenditures are expected to be in the range of $80 million to $90 million.

Webcast Information

Participants may Register Here for this conference call or copy and paste the following text into your browser: http://www.directeventreg.com/registration/event/3686447. After registering, participants will receive a confirmation through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. To ensure participants are connected for the full call, please register at least 10 minutes before the start of the call. The live webcast will also be accessible via the "Events Calendar” section of the Company’s Investor Relations website, www.investors.ads-pipe.com. An archived version of the webcast will be available following the call.

About the Company

Advanced Drainage Systems is a leading provider of innovative water management solutions in the stormwater and on-site septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplace. For over 50 years, the Company has been manufacturing a variety of innovative and environmentally friendly alternatives to traditional materials. Its innovative products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. The Company has established a leading position in many of these end markets by leveraging its national sales and distribution platform, overall product breadth and scale and manufacturing excellence. Founded in 1966, the Company operates a global network of approximately 60 manufacturing plants and 30 distribution centers. To learn more about ADS, please visit the Company’s website at www.ads-pipe.com.

Forward Looking Statements

Certain statements in this press release may be deemed to be forward-looking statements. These statements are not historical facts but rather are based on the Company’s current expectations, estimates and projections regarding the Company’s business, operations and other factors relating thereto. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “confident” and similar expressions are used to identify these forward-looking statements. Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include: fluctuations in the price and availability of resins and other raw materials and our ability to pass any increased costs of raw materials on to our customers in a timely manner; volatility in general business and economic conditions in the markets in which we operate, including the adverse impact on the U.S. and global economy of the COVID-19 global pandemic, and the impact of COVID-19 in the near, medium and long-term on our business, results of operations, financial position, liquidity or cash flows, and other factors relating to availability of credit, interest rates, fluctuations in capital and business and consumer confidence; cyclicality and seasonality of the non-residential and residential construction markets and infrastructure spending; the risks of increasing competition in our existing and future markets, including competition from both manufacturers of high performance thermoplastic corrugated pipe and manufacturers of products using alternative materials; uncertainties surrounding the integration of acquisitions and similar transactions, including the acquisition of Infiltrator Water Technologies and the integration of Infiltrator Water Technologies; our ability to realize the anticipated benefits from the acquisition of Infiltrator Water Technologies; risks that the acquisition of Infiltrator Water Technologies and related transactions may involve unexpected costs, liabilities or delays; our ability to continue to convert current demand for concrete, steel and polyvinyl chloride (“PVC”) pipe products into demand for our high performance thermoplastic corrugated pipe and Allied Products; the effect of any claims, litigation, investigations or proceedings; the effect of weather or seasonality; the loss of any of our significant customers; the risks of doing business internationally; our ability to remediate the material weakness in our internal control over financial reporting, including remediation of the control environment for our joint venture affiliate ADS Mexicana, S.A. de C.V.; the risks of conducting a portion of our operations through joint ventures; our ability to expand into new geographic or product markets, including risks associated with new markets and products associated with our recent acquisition of Infiltrator Water Technologies; our ability to achieve the acquisition component of our growth strategy; the risk associated with manufacturing processes; our ability to manage our assets; the risks associated with our product warranties; our ability to manage our supply purchasing and customer credit policies; the risks associated with our self-insured programs; our ability to control labor costs and to attract, train and retain highly-qualified employees and key personnel; our ability to protect our intellectual property rights; changes in laws and regulations, including environmental laws and regulations; our ability to project product mix; the risks associated with our current levels of indebtedness, including borrowings under our existing credit agreement and outstanding indebtedness under our existing senior notes; fluctuations in our effective tax rate; our ability to meet future capital requirements and fund our liquidity needs; the risk that additional information may arise that would require the Company to make additional adjustments or revisions or to restate the financial statements and other financial data for certain prior periods and any future periods; any delay in the filing of any filings with the Securities and Exchange Commission (“SEC”); the review of potential weaknesses or deficiencies in the Company’s disclosure controls and procedures, and discovering weaknesses of which we are not currently aware or which have not been detected; additional uncertainties related to accounting issues generally; and the other risks and uncertainties described in the Company’s filings with the SEC. New risks and uncertainties emerge from time to time and it is not possible for the Company to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. In light of the significant uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the Company’s expectations, objectives or plans will be achieved in the timeframe anticipated or at all. Investors are cautioned not to place undue reliance on the Company’s forward-looking statements and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Financial Statements

ADVANCED DRAINAGE SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(unaudited)

 
 

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Amounts in thousands, except per share data)

2020

 

 

2019

 

 

2020

 

 

2019

 

Net sales

$

486,145

 

 

$

393,424

 

 

$

1,538,971

 

 

$

1,303,037

 

Cost of goods sold

 

317,640

 

 

 

270,066

 

 

 

976,106

 

 

 

926,703

 

Cost of goods sold - ESOP special dividend compensation

 

-

 

 

 

-

 

 

 

-

 

 

 

168,610

 

Gross profit

 

168,505

 

 

 

123,358

 

 

 

562,865

 

 

 

207,724

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

30,537

 

 

 

29,967

 

 

 

89,283

 

 

 

86,303

 

General and administrative

 

36,069

 

 

 

37,023

 

 

 

104,800

 

 

 

116,486

 

Selling, general and administrative - ESOP special dividend compensation

 

-

 

 

 

-

 

 

 

-

 

 

 

78,142

 

Loss on disposal of assets and costs from exit and disposal activities

 

980

 

 

 

1,755

 

 

 

3,254

 

 

 

4,466

 

Intangible amortization

 

17,956

 

 

 

13,593

 

 

 

53,893

 

 

 

24,435

 

Income (loss) from operations

 

82,963

 

 

 

41,020

 

 

 

311,635

 

 

 

(102,108

)

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

8,433

 

 

 

13,191

 

 

 

27,763

 

 

 

70,787

 

Derivative (gains) loss and other (income) expense, net

 

(165

)

 

 

39

 

 

 

(883

)

 

 

118

 

Income (loss) before income taxes

 

74,695

 

 

 

27,790

 

 

 

284,755

 

 

 

(173,013

)

Income tax expense

 

20,264

 

 

 

4,032

 

 

 

79,291

 

 

 

22,855

 

Equity in net loss (income) of unconsolidated affiliates

 

390

 

 

 

99

 

 

 

150

 

 

 

(538

)

Net income (loss)

 

54,041

 

 

 

23,659

 

 

 

205,314

 

 

 

(195,330

)

Less: net income attributable to noncontrolling interest

 

267

 

 

 

371

 

 

 

838

 

 

 

149

 

Net income (loss) attributable to ADS

 

53,774

 

 

 

23,288

 

 

 

204,476

 

 

 

(195,479

)

Dividends to redeemable convertible preferred stockholders

 

(1,288

)

 

 

(1,334

)

 

 

(3,983

)

 

 

(9,530

)

Dividends paid to unvested restricted stockholders

 

-

 

 

 

(3

)

 

 

(2

)

 

 

(335

)

Net income (loss) available to common stockholders and participating securities

 

52,486

 

 

 

21,951

 

 

 

200,491

 

 

 

(205,344

)

Undistributed income allocated to participating securities

 

(7,798

)

 

 

(2,822

)

 

 

(31,699

)

 

 

-

 

Net income (loss) available to common stockholders

$

44,688

 

 

$

19,129

 

 

$

168,792

 

 

$

(205,344

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

70,450

 

 

 

68,508

 

 

 

69,893

 

 

 

62,119

 

Diluted

 

71,586

 

 

 

69,298

 

 

 

70,853

 

 

 

62,119

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.63

 

 

$

0.28

 

 

$

2.42

 

 

$

(3.31

)

Diluted

$

0.62

 

 

$

0.28

 

 

$

2.38

 

 

$

(3.31

)

Cash dividends declared per share

$

0.09

 

 

$

0.09

 

 

$

0.27

 

 

$

1.27

 

ADVANCED DRAINAGE SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(unaudited)

 

As of

 

(Amounts in thousands)

December 31, 2020

 

 

March 31, 2020

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash

$

223,996

 

 

$

174,233

 

Receivables, net

 

188,744

 

 

 

200,028

 

Inventories

 

238,860

 

 

 

282,398

 

Other current assets

 

11,934

 

 

 

9,552

 

Total current assets

 

663,534

 

 

 

666,211

 

Property, plant and equipment, net

 

496,052

 

 

 

481,380

 

Other assets:

 

 

 

 

 

 

 

Goodwill

 

598,957

 

 

 

597,819

 

Intangible assets, net

 

501,812

 

 

 

555,338

 

Other assets

 

82,081

 

 

 

69,140

 

Total assets

$

2,342,436

 

 

$

2,369,888

 

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current maturities of debt obligations

$

7,000

 

 

$

7,955

 

Current maturities of finance lease obligations

 

18,957

 

 

 

20,382

 

Accounts payable

 

108,368

 

 

 

106,710

 

Other accrued liabilities

 

119,956

 

 

 

101,116

 

Accrued income taxes

 

23,278

 

 

 

2,050

 

Total current liabilities

 

277,559

 

 

 

238,213

 

Long-term debt obligations, net

 

783,874

 

 

 

1,089,368

 

Long-term finance lease obligations

 

34,007

 

 

 

44,501

 

Deferred tax liabilities

 

167,645

 

 

 

175,616

 

Other liabilities

 

52,453

 

 

 

37,608

 

Total liabilities

 

1,315,538

 

 

 

1,585,306

 

Mezzanine equity:

 

 

 

 

 

 

 

Redeemable convertible preferred stock

 

255,491

 

 

 

269,529

 

Deferred compensation — unearned ESOP shares

 

(13,952

)

 

 

(22,432

)

Total mezzanine equity

 

241,539

 

 

 

247,097

 

Stockholders’ equity:

 

 

 

 

 

 

 

Common stock

 

11,567

 

 

 

11,555

 

Paid-in capital

 

882,843

 

 

 

827,573

 

Common stock in treasury, at cost

 

(10,949

)

 

 

(10,461

)

Accumulated other comprehensive loss

 

(24,353

)

 

 

(35,325

)

Retained (deficit) earnings

 

(86,903

)

 

 

(267,619

)

Total ADS stockholders’ equity

 

772,205

 

 

 

525,723

 

Noncontrolling interest in subsidiaries

 

13,154

 

 

 

11,762

 

Total stockholders’ equity

 

785,359

 

 

 

537,485

 

Total liabilities, mezzanine equity and stockholders’ equity

$

2,342,436

 

 

$

2,369,888

 

ADVANCED DRAINAGE SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 
 

 

Nine Months Ended December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

Cash Flow from Operating Activities

 

 

 

 

 

 

 

Net income (loss)

$

205,314

 

 

$

(195,330

)

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

107,321

 

 

 

74,432

 

Deferred income taxes

 

(8,032

)

 

 

(1,098

)

Loss on disposal of assets and costs from exit and disposal activities

 

3,254

 

 

 

4,466

 

ESOP and stock-based compensation

 

45,413

 

 

 

27,365

 

ESOP special dividend compensation

 

-

 

 

 

246,752

 

Amortization of deferred financing charges

 

293

 

 

 

34,380

 

Inventory step up related to Infiltrator Water Technologies acquisition

 

-

 

 

 

7,880

 

Fair market value adjustments to derivatives

 

(2,537

)

 

 

903

 

Equity in net loss (income) of unconsolidated affiliates

 

150

 

 

 

(538

)

Other operating activities

 

6,162

 

 

 

(6,013

)

Changes in working capital:

 

 

 

 

 

 

 

Receivables

 

12,502

 

 

 

50,865

 

Inventories

 

46,809

 

 

 

43,317

 

Prepaid expenses and other current assets

 

(2,288

)

 

 

(1,417

)

Accounts payable, accrued expenses, and other liabilities

 

34,415

 

 

 

10,354

 

Net cash provided by operating activities

 

448,776

 

 

 

296,318

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

Capital expenditures

 

(57,675

)

 

 

(46,293

)

Cash paid for acquisitions, net of cash acquired

 

-

 

 

 

(1,089,322

)

Other investing activities

 

516

 

 

 

(247

)

Net cash used in investing activities

 

(57,159

)

 

 

(1,135,862

)

Cash Flows from Financing Activities

 

 

 

 

 

 

 

Proceeds from Term Loan Facility

 

-

 

 

 

1,300,000

 

Payments on Term Loan Facility

 

-

 

 

 

(1,300,000

)

Proceeds from syndication of Term Loan Facility

 

-

 

 

 

700,000

 

Payments on syndicated Term Loan Facility

 

(205,250

)

 

 

(50,000

)

Proceeds from Senior Notes

 

-

 

 

 

350,000

 

Proceeds from Revolving Credit Agreement

 

-

 

 

 

177,900

 

Payments on Revolving Credit Agreement

 

(100,000

)

 

 

(177,900

)

Debt issuance costs

 

-

 

 

 

(34,606

)

Proceeds from PNC Credit Agreement

 

-

 

 

 

253,900

 

Payments on PNC Credit Agreement

 

-

 

 

 

(388,300

)

Payments on Prudential Senior Notes

 

-

 

 

 

(100,000

)

Payments on finance lease obligations

 

(15,859

)

 

 

(18,424

)

Proceeds from common stock offering, net of offering costs

 

-

 

 

 

293,648

 

Cash dividends paid

 

(24,507

)

 

 

(83,846

)

Proceeds from exercise of stock options

 

3,989

 

 

 

6,280

 

Other financing activities

 

(1,489

)

 

 

(236

)

Net cash used in financing activities

 

(343,116

)

 

 

928,416

 

Effect of exchange rate changes on cash

 

1,262

 

 

 

549

 

Net change in cash

 

49,763

 

 

 

89,421

 

Cash at beginning of period

 

174,233

 

 

 

8,891

 

Cash at end of period

$

223,996

 

 

$

98,312

 

Selected Financial Data

The following tables set forth net sales by reportable segment for each of the periods indicated.

 

Three Months Ended

 

 

December 31, 2020

 

 

December 30, 2019

 

 

Net Sales

 

 

Intersegment
Net Sales

 

 

Net Sales
from External
Customers

 

 

Net Sales

 

 

Intersegment
Net Sales

 

 

Net Sales
from External
Customers

 

Pipe

$

254,209

 

 

$

(1,311

)

 

$

252,898

 

 

$

207,897

 

 

$

(342

)

 

$

207,555

 

Infiltrator Water Technologies

 

98,409

 

 

 

(17,188

)

 

 

81,221

 

 

 

72,083

 

 

 

(13,549

)

 

 

58,534

 

International

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

International - Pipe

 

33,729

 

 

 

(2,970

)

 

 

30,759

 

 

 

28,340

 

 

 

 

 

 

28,340

 

International - Allied Products

 

11,648

 

 

 

 

 

 

11,648

 

 

 

10,114

 

 

 

 

 

 

10,114

 

Total International

 

45,377

 

 

 

(2,970

)

 

 

42,407

 

 

 

38,454

 

 

 

 

 

 

38,454

 

Allied Products & Other

 

109,619

 

 

 

 

 

 

109,619

 

 

 

88,881

 

 

 

 

 

 

88,881

 

Intersegment Eliminations

 

(21,469

)

 

 

21,469

 

 

 

 

 

 

(13,891

)

 

 

13,891

 

 

 

 

Total Consolidated

$

486,145

 

 

$

 

 

$

486,145

 

 

$

393,424

 

 

$

 

 

$

393,424

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

December 31, 2020

 

 

December 30, 2019

 

 

Net Sales

 

 

Intersegment
Net Sales

 

 

Net Sales
from External
Customers

 

 

Net Sales

 

 

Intersegment
Net Sales

 

 

Net Sales
from External
Customers

 

Pipe

$

819,994

 

 

$

(4,793

)

 

$

815,201

 

 

$

751,483

 

 

$

(684

)

 

$

750,799

 

Infiltrator Water Technologies

 

306,548

 

 

 

(53,948

)

 

 

252,600

 

 

 

136,972

 

 

 

(25,738

)

 

 

111,234

 

International

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

International - Pipe

 

96,271

 

 

 

(3,866

)

 

 

92,405

 

 

 

92,242

 

 

 

 

 

 

92,242

 

International - Allied Products

 

34,233

 

 

 

 

 

 

34,233

 

 

 

33,330

 

 

 

 

 

 

33,330

 

Total International

 

130,504

 

 

 

(3,866

)

 

 

126,638

 

 

 

125,572

 

 

 

 

 

 

125,572

 

Allied Products & Other

 

344,532

 

 

 

 

 

 

344,532

 

 

 

315,432

 

 

 

 

 

 

315,432

 

Intersegment Eliminations

 

(62,607

)

 

 

62,607

 

 

 

 

 

 

(26,422

)

 

 

26,422

 

 

 

 

Total Consolidated

$

1,538,971

 

 

$

 

 

$

1,538,971

 

 

$

1,303,037

 

 

$

 

 

$

1,303,037

 

Employee Stock Ownership Plan (“ESOP”)

The Company established an ESOP to enable employees to acquire stock ownership in ADS in the form of redeemable convertible preferred shares (“preferred shares”). All preferred shares will be converted to common shares by plan maturity, which will be no later than March 2023. The ESOP’s conversion of preferred shares into common shares will have a meaningful impact on net income, net income per share and common shares outstanding. The common shares outstanding will be greater after conversion.

Net Income (Loss)

The impact of the ESOP on net (loss) income includes the ESOP deferred compensation attributable to the preferred shares allocated to employee accounts during the period, which is a non-cash charge to our earnings and not deductible for income tax purposes.

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

 

2020

 

 

2019

 

Net income (loss) attributable to ADS

$

53,774

 

 

$

23,288

 

 

$

204,476

 

 

$

(195,479

)

ESOP deferred stock-based compensation

$

13,513

 

 

$

7,411

 

 

$

29,506

 

 

$

18,481

 

ESOP special dividend compensation

$

-

 

 

$

-

 

 

$

-

 

 

$

246,752

 

Common shares outstanding

The conversion of the preferred shares will increase the number of common shares outstanding. Preferred shares will convert to common shares at plan maturity, or upon retirement, disability, death or vested terminations over the life of the plan.

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Shares in thousands)

2020

 

 

2019

 

 

2020

 

 

2019

 

Weighted average common shares outstanding - Basic

 

70,450

 

 

 

68,508

 

 

 

69,893

 

 

 

62,119

 

Conversion of preferred shares

 

15,760

 

 

 

17,073

 

 

 

16,213

 

 

 

17,252

 

Unvested restricted shares

 

-

 

 

 

41

 

 

 

-

 

 

 

41

 

Non-GAAP Financial Measures

This press release contains financial information determined by methods other than in accordance with accounting principles generally accepted in the United States of America (“GAAP”). ADS management uses non-GAAP measures in its analysis of the Company’s performance. Investors are encouraged to review the reconciliation of non-GAAP financial measures to the comparable GAAP results available in the accompanying tables.

Reconciliation of Non-GAAP Financial Measures

This press release includes references to organic results, Adjusted EBITDA and Free Cash Flow, non-GAAP financial measures. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP. These measures are not intended to be substitutes for those reported in accordance with GAAP. Adjusted EBITDA and Free Cash Flow may be different from non-GAAP financial measures used by other companies, even when similar terms are used to identify such measures.

EBITDA and Adjusted EBITDA are non-GAAP financial measures that comprise net income before interest, income taxes, depreciation and amortization, stock-based compensation, non-cash charges and certain other expenses. The Company’s definition of Adjusted EBITDA may differ from similar measures used by other companies, even when similar terms are used to identify such measures. Adjusted EBITDA is a key metric used by management and the Company’s board of directors to assess financial performance and evaluate the effectiveness of the Company’s business strategies. Accordingly, management believes that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as the Company’s management and board of directors. In order to provide investors with a meaningful reconciliation, the Company has provided below reconciliations of Adjusted EBITDA to net income.

Free Cash Flow is a non-GAAP financial measure that comprises cash flow from operating activities less capital expenditures. Free Cash Flow is a measure used by management and the Company’s board of directors to assess the Company’s ability to generate cash. Accordingly, management believes that Free Cash Flow provides useful information to investors and others in understanding and evaluating our ability to generate cash flow from operations after capital expenditures. In order to provide investors with a meaningful reconciliation, the Company has provided below a reconciliation of cash flow from operating activities to Free Cash Flow.

The following tables present a reconciliation of EBITDA and Adjusted EBITDA to Net Income and Free Cash Flow to Cash Flow from Operating Activities, the most comparable GAAP measures, for each of the periods indicated.

Reconciliation of Segment Adjusted Gross Profit to Gross profit

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

 

2020

 

 

2019

 

Segment Adjusted Gross Profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pipe

$

78,651

 

 

$

61,025

 

 

$

269,746

 

 

$

192,764

 

International

 

12,986

 

 

 

9,066

 

 

 

38,976

 

 

 

29,134

 

Infiltrator Water Technologies

 

48,518

 

 

 

34,735

 

 

 

149,551

 

 

 

64,879

 

Allied Products & Other

 

55,158

 

 

 

42,818

 

 

 

176,006

 

 

 

157,626

 

Intersegment Elimination

 

(932

)

 

 

(881

)

 

 

(918

)

 

 

(1,859

)

Total Segment Adjusted Gross Profit

 

194,381

 

 

 

146,763

 

 

 

633,361

 

 

 

442,544

 

Depreciation and amortization

 

16,432

 

 

 

16,025

 

 

 

49,318

 

 

 

45,417

 

ESOP and stock-based compensation expense

 

9,444

 

 

 

5,273

 

 

 

20,981

 

 

 

12,913

 

ESOP special dividend compensation

 

-

 

 

 

-

 

 

 

-

 

 

 

168,610

 

COVID-19 related expenses

 

-

 

 

 

-

 

 

 

197

 

 

 

-

 

Inventory step up related to Infiltrator Water Technologies acquisition

 

-

 

 

 

2,107

 

 

 

-

 

 

 

7,880

 

Total Gross Profit

$

168,505

 

 

$

123,358

 

 

$

562,865

 

 

$

207,724

 

Reconciliation of Adjusted EBITDA to Net Income

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

 

2020

 

 

2019

 

Net income (loss)

$

54,041

 

 

$

23,659

 

 

$

205,314

 

 

$

(195,330

)

Depreciation and amortization

 

35,762

 

 

 

31,172

 

 

 

107,321

 

 

 

74,432

 

Interest expense

 

8,433

 

 

 

13,191

 

 

 

27,763

 

 

 

70,787

 

Income tax expense

 

20,264

 

 

 

4,032

 

 

 

79,291

 

 

 

22,855

 

EBITDA

 

118,500

 

 

 

72,054

 

 

 

419,689

 

 

 

(27,256

)

Loss on disposal of assets and costs from exit and disposal activities

 

980

 

 

 

1,755

 

 

 

3,254

 

 

 

4,466

 

ESOP and stock-based compensation expense

 

18,325

 

 

 

11,283

 

 

 

45,413

 

 

 

27,365

 

ESOP special dividend compensation

 

-

 

 

-

 

 

 

-

 

 

 

246,752

 

Transaction costs

 

54

 

 

 

1,814

 

 

 

1,428

 

 

 

22,649

 

Inventory step up related to Infiltrator Water Technologies acquisition

 

-

 

 

 

2,107

 

 

 

-

 

 

 

7,880

 

Strategic growth and operational improvement initiatives

 

573

 

 

 

1,735

 

 

 

2,689

 

 

 

4,631

 

COVID-19 related expenses (a)

 

-

 

 

 

-

 

 

 

806

 

 

 

-

 

Other adjustments(b)

 

431

 

 

 

566

 

 

 

(872

)

 

 

3,287

 

Adjusted EBITDA

$

138,863

 

 

$

91,314

 

 

$

472,407

 

 

$

289,774

 

  (a)   Includes expenses directly related to our response to the COVID-19 pandemic, including adjustments to our pandemic pay program and expenses associated with our 3rd party crisis management vendor.
  (b)   Includes derivative fair value adjustments, foreign currency transaction (gains) losses, the proportionate share of interest, income taxes, depreciation and amortization related to the South American Joint Venture, which is accounted for under the equity method of accounting and executive retirement expense. The other adjustments in fiscal 2020 also includes expenses related to the ADS Mexicana’s investigation.

Reconciliation of Segment Adjusted EBITDA

 

Three Months Ended

 

 

Nine Months Ended

 

 

December 31,

 

 

December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

 

2020

 

 

2019

 

Legacy ADS Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pipe Adjusted Gross Profit

$

78,651

 

 

$

61,025

 

 

$

269,746

 

 

$

192,764

 

International Adjusted Gross Profit

 

12,986

 

 

 

9,066

 

 

 

38,976

 

 

 

29,134

 

Allied Products & Other Adjusted Gross Profit

 

55,158

 

 

 

42,818

 

 

 

176,006

 

 

 

157,626

 

Unallocated corporate and selling expenses

 

(48,726

)

 

 

(47,257

)

 

 

(141,819

)

 

 

(139,489

)

Legacy ADS Adjusted EBITDA

 

98,069

 

 

 

65,652

 

 

 

342,909

 

 

 

240,035

 

Legacy Infiltrator Water Technologies Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Infiltrator Water Technologies

 

48,518

 

 

 

34,735

 

 

 

149,551

 

 

 

64,879

 

Unallocated corporate and selling expenses

 

(6,994

)

 

 

(8,192

)

 

 

(19,525

)

 

 

(13,281

)

Legacy Infiltrator Water Technologies Adjusted EBITDA

$

41,524

 

 

$

26,543

 

 

$

130,026

 

 

$

51,598

 

Intersegment Eliminations

 

(730

)

 

 

(881

)

 

 

(528

)

 

 

(1,859

)

Consolidated Adjusted EBITDA

$

138,863

 

 

$

91,314

 

 

$

472,407

 

 

$

289,774

 

Reconciliation of Free Cash Flow to Cash flow from Operating Activities

 

Nine Months Ended December 31,

 

(Amounts in thousands)

2020

 

 

2019

 

Net cash flow from operating activities

$

448,776

 

 

$

296,318

 

Capital expenditures

 

(57,675

)

 

 

(46,293

)

Free cash flow

$

391,101

 

 

$

250,025

 

 

FAQ

What were the net sales for Advanced Drainage Systems in Q3 FY2021?

Net sales for Advanced Drainage Systems in Q3 FY2021 were $486.1 million, an increase of 23.6% compared to the previous year.

How much did the net income increase for ADS in Q3 FY2021?

The net income for ADS in Q3 FY2021 increased by 128.4% to $54.0 million.

What is the adjusted EBITDA for ADS in the third quarter?

The adjusted EBITDA for Advanced Drainage Systems in the third quarter was $138.9 million, reflecting a 52.1% increase.

What is ADS's updated sales guidance for FY2021?

ADS updated its sales guidance for FY2021 to a range of $1.915 billion to $1.950 billion.

ADVANCED DRAINAGE SYSTEMS, INC.

NYSE:WMS

WMS Rankings

WMS Latest News

WMS Stock Data

8.98B
70.33M
8.99%
88.78%
2.23%
Building Products & Equipment
Plastics Foam Products
Link
United States of America
HILLIARD